Product
OTT166
1 clinical trial
1 indication
Indication
Diabetic RetinopathyClinical trial
OTT166-201 A Phase 2 Randomized, Double-Masked, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of OTT166 Ophthalmic Solution in the Treatment of Diabetic Retinopathy (DR)Status: Completed, Estimated PCD: 2023-12-29